Sarah Cooleybeck spoke with Managing IP about business opportunities stemming from patent licensing agreements in the life sciences sector. She discussed the increase in deals involving the combinations of two parties' technologies, sharing: "There are a lot of options that parties can consider when deciding who should own the IP."

Read the full article. (Subscription required)